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42 Abbreviations table:
Abbreviation Full term or phrase
QoL quality of life
HSCT haemopoietic stem cell transplantation
TBI total body irradiation
DEXA dual energy X-ray absorptiometry
HOMA-IR homeostatic model assessment of insulin 
resistance
peak𝑉O2 peak rate of oxygen uptake
SF-36 36-Item Short Form Health Survey
SD standard deviation
MMQL Minneapolis-Manchester Quality of Life 
Instrument
GHD growth hormone deficiency
GH growth hormone
PRT progressive resistance training programme
CNS central nervous system
GVHD graft versus host disease
ITT insulin tolerance test
BMI body mass index
BMISDS body mass index standard deviation score
ECHO echocardiogram
FVC forced vital capacity
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FEV1 forced expiratory volume in first second
SDS standard deviation score
VT ventilation threshold
Pulse O2 the rate of oxygen uptake per heart beat (𝑉
/heart rate (HR))O2
HR heart rate
RER respiratory exchange ratio
ANOVA one-way withinrepeated  measures analysis 
of variance 
FVCSDS forced vital capacity standard deviation 
score
LSD post-hocFisher’s least significance 
difference method
GLUT-4 glucose transporter protein
AMPK AMP-activated protein kinase
Akt protein kinase B substrate
T2DM type 2 diabetes mellitus
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46 Abstract
47 Purpose: To investigate the effects of a supervised combined resistance and aerobic 
48 training programme on cardiorespiratory fitness, body composition, insulin resistance and 
49 quality of life(QoL) in survivors of childhood hematopoietic stem cell 
50 transplantation(HSCT) with total body irradiation(TBI).
51 Participants: HSCT/TBI survivors(n=20; 8 Female). Mean(range) for age at and time 
52 since HSCT/TBI was 16.7(10.9-24.5) and 8.4(2.3-16.0)yrs respectively.
53 Methods: After a 6-month run-in, participants undertook supervised 45-60-minute 
54 resistance and aerobic training twice-weekly for 6 months, with a 6-month follow-up. 
55 The following assessments were made at 0, 6(start of exercise programme), 12(end of 
56 exercise programme) and 18 months: Body composition via dual energy X-ray 
57 absorptiometry(DEXA), homeostatic model assessment of insulin resistance(HOMA-IR), 
58 cardiorespiratory fitness(treadmill based peak rate of oxygen uptake peak) test), QoL (𝑉O2
59 questionnaires(36-Item Short Form Health Survey(SF-36) and Minneapolis-Manchester 
60 Quality of Life Instrument(MMQL).
61 Results: Results expressed as mean(SD) or geometric mean(range). There were 
62 significant improvements in peak(35.7(8.9)vs.41.7(16.1)mL/min/kg, P=0.05), fasted 𝑉O2
63 plasma insulin(16.56(1.48-72.8)vs.12.62(1.04-54.97)mIU/L, P=0.03), and HOMA-
64 IR(3.65(0.30-17.26)vs.2.72(0.22-12.89), P=0.02) after the exercise intervention. There 
65 were also significant improvements in the SF-36 QoL general health 
66 domain(69.7(14.3)vs.72.7(16.0), P<0.001) and the MMQL school domain 
67 (69.1(25.2)vs.(79.3(21.6), P=0.03) during the exercise intervention. No significant 
68 changes were observed in percentage body fat, fat mass or lean mass.
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69 Conclusion: The supervised 6/12 combined resistance and aerobic exercise programme 
70 significantly improved cardiorespiratory fitness, insulin resistance and QoL in childhood 
71 HSCT/TBI survivors, with no change in body composition, suggesting a metabolic 
72 training effect on muscle. These data support a role for targeted physical rehabilitation 
73 services in this group at high risk of diabetes and cardiovascular disease.
74
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75 Introduction
76 HSCT with TBI has significantly improved survival in childhood leukaemia but is 
77 associated with important long-term sequelae1 2. Survivors demonstrate central 
78 adiposity3, reduced lean mass4, and risk factors for the metabolic syndrome5 including 
79 increased blood pressure1, dyslipidaemia5, insulin resistance, diabetes6 3, and impaired β-
80 cell function7. Growth hormone deficiency (GHD) after TBI also predisposes to these 
81 morbidities but they persist despite growth hormone (GH) treatment8.
82 QoL in HSCT survivors is variable and whilst longer term studies are still needed in 
83 children9, adults experience physical, cognitive and social difficulties, and fatigue2 10. 
84 Children with leukemia have reduced physical fitness, partly due to inactivity10 11, but 
85 exercise has shown benefit, including to children after HSCT12 13 14 15. More generally, 
86 exercise programmes improve cancer treatment related fatigue and QoL 17 18 19.
87 Aerobic activity is the most commonly used intervention for reducing cardiovascular 
88 risk16, and reduces visceral fat17, insulin resistance18, and blood pressure19 20 in both 
89 adults and children. Progressive resistance training (PRT) also confers improvement in 
90 cardiovascular risk20 21 22, and is becoming more widely utilised with potential benefit in 
91 increasing lean body mass23 24 of particular relevance to HSCT/TBI survivors 25. 
92 HSCT/TBI survivors therefore have a range of factors which may benefit from exercise 
93 rehabilitation including PRT. Our aim was to conduct a supervised combined aerobic and 
94 PRT in childhood survivors of HSCT/TBI, to examine effects on fitness, body 
95 composition, insulin resistance, and QoL.
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96 Method
97 Ethical Approval: This study was conducted in accordance with the Declaration of 
98 Helsinki following approval by the NHS South West Frenchay Research Ethics 
99 Committee. Written informed consent was obtained from all participants.
100 Participants: Children/adolescents followed up after HSCT/TBI for haematological 
101 malignancy at a single regional centre between 1993-2004 were identified via the 
102 endocrine database and the Leukaemia registry. Eligible participants  were those on GH 
103 replacement for GHD (to control for GH status)26 27. Participants were approached by 
104 their late effects team and 24 consented to participate. All were >1 year post-HSCT/TBI 
105 or any oncology or steroid treatment. 
106 All were on GH treatment for >6months before study enrolment, for GHD diagnosed by 
107 standard insulin tolerance test (ITT) after documentation of poor growth.  Demographic 
108 and oncology treatment data of participants are shown in Table 1.
109 Study Design: A within-subject longitudinal repeated measures study, frequently used in 
110 Sports science research28. Baseline data collection was performed at study entry (time1) 
111 and after a 6-month period of habitual activity and GH treatment (time2) to assess 
112 changes over time not attributable to the subsequent exercise intervention. A 6-month 
113 supervised aerobic and PRT followed with data collection at the end of the intervention 
114 (time3) and again, after a further 6-months (time4).
115 Data Collection: At each time point included auxology, body composition assessment 
116 with DEXA, HOMA-IR, cardiorespiratory fitness peak test, and QoL questionnaires 𝑉O2
117 (SF-36 and MMQL).
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118 Auxology: Height was measured to the nearest mm using a wall-mounted Harpenden® 
119 stadiometer (Holtain, Crymych, UK) calibrated daily, body weight to the nearest 0.1kg 
120 using a single set of scales (Seca®,Hamburg, Germany), both using standard auxology 
121 procedures29. Pubertal status was assessed using standard Tanner staging30, by a single 
122 observer (ND). For males, only pubic hair and virilisation of the external genitalia were 
123 used, as testicular volume is not a reliable marker of puberty due to sertoli cell damage. 
124 Body mass index (BMI) was calculated as weight/height2(kg/m2) and converted to body 
125 mass index standard deviation score (BMISDS) using Cole’s method31. 
126 Body Composition:  DEXA fan-beam technique (Lunar Prodigy DF+15048 series, GE 
127 Healthcare, Madison, Wisconsin, USA) was used to differentiate whole body fat, lean 
128 mass, and percentage trunk fat.
129 QoL questionnaires: All participants (those<16 years with parental assistance) 
130 completed SF-36, a generic health related QoL measure for adults with chronic disease 
131 including cancer survivors32 and those with GHD33. The SF-36 is well validated, widely 
132 used, and comprises 36 questions on general health and well-being during the previous 4 
133 weeks. Data are presented as T scores i.e. are normalised with mean(SD) of 50(10). 
134 Higher scores indicate better quality of life. One or more SDs below the population mean 
135 demonstrates poor QoL. MMQL is a specific measure for childhood cancer survivors <18 
136 years, demonstrated to show validity and reliability, with versions for youth, adolescents, 
137 and parents and carers of children. It is a comprehensive, multidimensional self-report 
138 instrument across 5 scales including physical, emotional, social, school and body image.  
139 It is the only questionnaire assessing satisfaction with appearance, potentially an 
140 important aspect for childhood cancer survivors34. Previous studies have shown that 
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141 childhood cancer survivors show similar overall QoL to controls with mean scores of 4/5 
142 or 80%34.
143 Assays: Laboratories were Clinical Pathology Accredited. Plasma samples for glucose 
144 were assayed within 4hrs (Olympus AU640 or AU2700 clinical chemistry analyser, 
145 Olympus, Hamburg, Germany). A commercially available ELISA kit (Human Insulin 
146 KAP1251 (MDC 0.15μIU/mL and CV 5.3%), BioSource Europe S.A., Nivelles, 
147 Belgium) was used to determine plasma insulin concentrations. The maximum time to 
148 assay was 24 months using plasma/serum samples frozen at -80oC.
149 HOMA-IR: Venous blood (3mL), collected between 08:00 and 10:00 following 
150 overnight fasting for 8 to 12 hr were analysed for plasma glucose and insulin 
151 concentrations. HOMA-IR was calculated as: fasted plasma insulin concentration(mIU/L) 
152 x fasted plasma glucose concentration(mmol/L)/22.535.
153 Exercise intervention: Participants were required to perform 45-60 minutes of exercise 
154 at least twice, but preferably three times per week. KT, an exercise physiologist 
155 experienced in training children and young people and special groups, designed the 
156 generic programme, which was supervised by ND and local gym trainers with 
157 appropriate qualifications for children and young people to ensure individual participant 
158 safety. ND monitored attendance and progress. Patient feedback and study retention 
159 demonstrated that the participants enjoyed the exercise programme and found it valuable.
160 In order to minimise the potential for an adverse cardiac event, each participant 
161 underwent an echocardiogram (ECHO), conducted and assessed by a cardiologist before 
162 proceeding with the intervention. All received an induction programme and were 
163 supervised at every session. They were asked to perform at least 15 minutes of self-
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164 selected aerobic activity at moderate intensity (60-70% of maximum HR) followed by 
165 ≥30 minutes of PRT using body weight or standard machine-based PRT equipment and 
166 involving at least 9 major muscle groups, at resistance loads of 60-80% 1RM. The 
167 programme involved a standard range of flexion and extension exercises tailored to the 
168 individual. Initially, participants performed 1 set of 18-20 repetitions, progressing over 6-
169 months to 3 sets of 10-12 repetitions for each muscle group. This approach minimised 
170 lean tissue loss initially, and maximised the likelihood of safe gains in lean mass.  At 
171 baseline and every 6 weeks, 1 repetition maximum (1RM) strength tests (leg press and 
172 chest press) were undertaken by qualified instructors to monitor gains in skeletal muscle 
173 strength. 
174 Isometric exercise was avoided due to the risk of cardiomyopathy from TBI and 
175 anthracycline toxicity. 
176 Exercise test outcome measurements: Forced vital capacity (FVC) and forced 
177 expiratory volume over the first second (FEV1) were measured using spirometry. Results 
178 were expressed as standard deviation scores (SDS) adjusted for age, gender and stature36. 
179 A modified Balke 2 protocol was used37 to measure peak; participants walked/jogged 𝑉O2
180 on a motorised treadmill belt with incremental changes in speed and inclination every 
181 two minutes until volitional exhaustion. Respiratory data collected including the rates of 
182 oxygen uptake and carbon dioxide elimination ( ). peak is traditionally 𝑉CO2 𝑉O2
183 expressed either in absolute terms (L/min) or relative to body mass (mL/min/kg), the 
184 latter assuming a constant relationship between lean mass and fat mass38. It is 
185 conventional to express measured peak data relative to body mass39 when comparing 𝑉O2
186 with published normal data for age and gender40 and absolute peak values were 𝑉O2
Page 11 of 38
John Wiley & Sons
Pediatric Blood & Cancer
Exercise intervention paper final version PBC
12
187 divided by body weight to yield relative data. The ventilatory threshold (VT) was 
188 assessed by the V-slope method41 and refers to the point where aerobic metabolism is 
189 supplemented by anaerobic mechanisms during progressive exercise, and can be 
190 expressed as occurring at a percentage of peak. Pulse O2 is the rate of oxygen uptake 𝑉O2
191 per heart beat ( /heart rate (HR)) and is a measure of circulatory efficiency increasing 𝑉O2
192 with stature, and therefore age, in childhood. Respiratory exchange ratio (RER) is the 
193 ratio / . Peak exercise tests were considered truly at peak if at least two of the 𝑉CO2 𝑉O2
194 following criteria were satisfied: a plateau (≤2 mL/min/kg) in the  profile over the 𝑉O2
195 final two exercise stages, HR ≥95% age-predicted maximum (220beats/min – 
196 chronological age) and/or RER ≥1.10. Exercise test outcome measures were , , 𝑉O2 𝑉CO2
197 VT, Pulse O2 and HR.
198 Statistical analyses: Statistical analyses were performed using IBM SPSS version 17.0 
199 (IBM Corporation, New York, USA). Statistical significance was accepted at P≤0.05. 
200 Normally distributed data were expressed as mean(SD). Skewed data were expressed as 
201 geometric mean(range) and log-transformed(log10) to normalise the distribution and 
202 facilitate the correct use of parametric statistical testing for between time comparisons. 
203 Parametric data were compared overall using repeated measures analysis of variance 
204 (ANOVA) followed by pairwise comparisons using the post-hoc Fisher’s least 
205 significance difference (LSD) method. As there were randomly missing data points, a 
206 repeated measures analysis using the ‘SAS mixed procedure’ was used for between time 
207 comparisons using ANOVA. This method uses a maximum likelihood method and 
208 automatically excludes missing data by using mixed modelling. In this data the strength 
209 of correlations between data at different time points did not vary significantly. 
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210 Proportions were compared using Chi-square or Fishers Exact tests when appropriate for 
211 smaller sample sizes. 
212 Results
213 Twenty-four participants consented to the study and 20(8 females:12 males) completed 
214 the supervised combined aerobic and PRT. Exercise diaries demonstrated 85% attended 
215 at least twice weekly and 35% attended 3 times weekly over the 6-month period): 4 were 
216 unable to complete the intervention (sickness =2; time constraints =2). Sixteen completed 
217 post-exercise intervention data collection (4 unavailable due to relocation out of region). 
218 None had conditions which precluded exercise; 6 had reduced fractional shortening on 
219 ECHO attributed to subclinical anthracyline toxicity. 
220 Baseline data (time1)
221 Cardiorespiratory fitness: Six participants displayed forced vital capacity standard 
222 deviation score (FVCSDS) <-3 suggesting restrictive lung deficits with mean maximal 
223 ventilation (FVCx40) reduced to <75% expected in healthy young people. However, as 𝑉
224  is the rate-limiting step, maximal ventilation is not usually reached during an exercise O2
225 test. Peak ventilation as a proportion of the predicted maximal ventilation (FVCx40) was 
226 mean(SD) 58.6(18.8)%. Only one patient exercised at maximal ventilatory capacity with 
227 a FVCSDS of -5.78.
228 peak divided by body mass was reduced at baseline (mean 35.7mL/min/kg) 𝑉O2
229 compared to published normal values for age and sex (females 39-45mL/min/kg and 
230 males 49-50mL/min/kg)40.
231 Body Composition: Female participants had significantly higher body fat and trunk fat 
232 than males: female body fat mean(SD) 41.7(8.2)%vs.male  24.3(13.5)%,P<0.001; female 
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233 trunk fat 42.8(10.7)%vs.male 24.7(14.0)%,P=0.004). Female participants also had higher 
234 body fat than published UK normal data for females of the same age42. HOMA-IR values 
235 were greater (mean(range) 3.65( 0.30-17.26)) than the published upper limit of normal 
236 (2.0= mean plus 2 SD)43. Sex differences were apparent in both fasted plasma insulin and 
237 HOMA-IR values, with higher levels in females: fasted plasma insulin mean (range) 25.0 
238 (6.5-50.0)vs.9.5 (2.6-68.3)µIU/mL,P=0.013; HOMA-IR mean(range) 5.0(1.3-
239 11.1)vs.2.2(0.5-18.3),P=0.047.
240 Baseline data (time2) 
241 End of run in period: There were no changes in cardio-respiratory fitness, body 
242 composition or insulin resistance during the run-in period (see Table 2) when participants 
243 were engaging in their usual level of habitual activity.
244 Impact of Exercise Intervention (times2-3) 
245 Body composition and insulin resistance: There were no significant changes in fat 
246 mass, lean mass or percentage body fat (Table 2) but significant improvements in 
247 markers of insulin resistance such as fasted plasma insulin concentrations (P=0.026) and 
248 HOMA-IR (P=0.024) following the exercise intervention, and maintained at 
249 time3vs.4(P=0.60 and P=0.06) respectively (Table 2, Figure 2).
250 Cardiorespiratory fitness: There were significant improvements in 𝑉O2
251 peak(mL/min/kg) (time2vs.3), which were maintained at time3vs.4(P=0.05) (Table 2, 
252 Figure 1). There were no further improvements during the follow-up period (time3vs.4) 
253 when participants were not in a formal exercise programme. Pulse O2 increased 
254 significantly with training (P=0.026). VT occurred at mean(SD) 72.0(11.9)% peak 𝑉O2
255 and did not change with training. Significant gains in strength were identified from 1RM 
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256 testing: mean(SD) 81.5(40.4)%,P<0.001 increase in leg strength and 
257 90.4(78.9)%,P<0.001 increase in chest strength. 
258 QoL: There were significant improvements in the SF-36 QoL general health domain 
259 during the exercise intervention: mean(SD)(69.7(14.3)vs.72.7(16.0),P<0.001), which 
260 were maintained at time3vs.4,P<0.05 (Figure 3). Data from the SF-36 QoL questionnaire 
261 identified significant improvements before the exercise intervention in physical health 
262 (85.2(13.8)vs.91.5(11.4),P=0.007); physical role (84.1(17.7)vs.94.4(9.5),P=0.012); 
263 emotional role (80.9(22.2)vs.91.3(16.6),P=0.023); social 
264 (84.1(24.1)vs.93.1(11.8),P=0.048); and total (69.1(25.2)vs.72.9(22.9),P=0.007) domains. 
265 Data from the MMQL QoL questionnaire showed improvements in the school domain 
266 (time2vs.time3) (69.1(25.2)vs.79.3(21.6),P=0.034). The MMQL also identified 
267 significant improvements in the physical health domain 12 months after the start of the 6-
268 month exercise intervention (time2vs.time 4) 66.4(25.3)vs.79.4(16.7),P=0.029), but not 
269 immediately after the exercise intervention (time2vs.time3). 
270 Discussion
271 This study reports a successfully implemented 6-month combined resistance and aerobic 
272 exercise intervention programme in young people after HSCT/TBI and demonstrated 
273 improved outcomes for insulin resistance, cardiorespiratory fitness, and some aspects of 
274 QoL. 
275 Cardiorespiratory fitness peakmL/min/kg) was lower at baseline than predicted (𝑉O2
276 values for age and sex in UK children17. peak is closely correlated to lean body mass, 𝑉O2
277 therefore, expressing peak relative to body mass (rather than lean body mass) may be 𝑉O2
278 expected to show reduced peak in HSCT/TBI survivors due to their abnormal body 𝑉O2
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279 composition with reduced lean mass and increased adiposity. GHD also reduces 
280 cardiorespiratory fitness, and GH treatment improves cardiorespiratory fitness and body 
281 composition but not strength in adults with GHD44. All study participants had been 
282 established on GH treatment for at least 6 months prior to baseline assessment (time1) to 
283 control for the effects of GH with usual activity before the exercise programme. 
284 There were no changes in cardio-respiratory fitness, body composition or insulin 
285 resistance during the six month period before the intervention. There was a significant 
286 improvement in cardiorespiratory fitness seen during the exercise intervention. This  may 
287 have been a larger effect due to reduced baseline cardiorespiratory fitness, related, in part, 
288 to de-conditioning from treatment. Significant improvement in Pulse O2 suggests 
289 improved circulatory efficiency. VT occurred at mean(SD) 72(11.9)% peak. This 𝑉O2
290 refers to the point where aerobic metabolism is supplemented by anaerobic mechanisms 
291 during progressive exercise. In healthy adults, published data suggests VT occurs 
292 between 45-65% peak. In the study group, there was no change in VT expressed as a 𝑉O2
293 percentage of peak, however, as peak increased significantly after the exercise 𝑉O2 𝑉O2
294 intervention, VT occurred at a higher VO2. VT as % peak is known to be increased in 𝑉O2
295 GH deficient adults (73%) and contributes to fatigue during activities of daily living44 45. 
296 The improvements seen in peak without a change in %VT may still improve fatigue. 𝑉O2
297 There were significant gains in leg and chest strength identified by the 1RM tests. This is 
298 not seen with GH treatment alone44, consistent with the lack of change seen during the 
299 run in period, and both GH treatment and exercise are required to regain full strength and 
300 fitness in GHD participants.
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301 A reduction in fat mass, an increase in lean mass or a reduction in percentage body fat 
302 may be expected to contribute to enhanced cardiorespiratory fitness and muscular 
303 strength, but significant changes in body composition were not seen during the 6-month 
304 training period. It may be that a larger sample, a longer intervention period, and/or longer 
305 follow-up are required to identify significant changes in body composition. 
306 As expected, the study group demonstrated higher HOMA-IR values at baseline 
307 compared to published normal data for adults and adolescents. In >1000 US adolescents, 
308 two thirds of whom had normal BMI, the mean(SEM) HOMA-IR for girls was 
309 2.93(0.11)vs.2.82(0.11) for boys46. These data are comparable for the male study 
310 participants whereas the female participants had a higher HOMA-IR. HSCT/TBI has 
311 been shown to be associated with increased abdominal adiposity and diabetes risk, related 
312 both to increased insulin resistance and reduced β-cell function7. Body composition after 
313 HSCT/TBI is abnormal with increased visceral and intra-muscular fat and reduced 
314 subcutaneous fat and lean mass7: this might specifically contribute to development of the 
315 metabolic syndrome and insulin resistance due to a failure of the adipose tissue to 
316 expand, as seen in lipodystrophy47. It is also well known that increased insulin resistance 
317 is associated with central adiposity, and with GHD and GH replacement both in adults 
318 and children48 49. All participants were receiving GH replacement therapy for the duration 
319 of the study, potentially impacting on baseline insulin and HOMA-IR levels, but this 
320 cannot have influenced the improvement in insulin resistance with exercise as GH 
321 treatment remained constant throughout. The significant reductions in insulin and 
322 HOMA-IR recorded during the exercise intervention are consistent with other reports of 
323 reduced insulin resistance with either aerobic18 or resistance training 50 51.
Page 17 of 38
John Wiley & Sons
Pediatric Blood & Cancer
Exercise intervention paper final version PBC
18
324 Previous studies have also reported improvements in insulin resistance without body 
325 composition changes52 suggesting that initial improvements relate to improved metabolic 
326 function of muscle. The mechanisms whereby exercise improves insulin resistance are 
327 complex53 54 and were not directly measured in this study. Both insulin and exercise 
328 promote an increase in glucose uptake in skeletal muscle, and involve an increase in 
329 translocation of the main glucose transporter protein (GLUT-4) from the intracellular 
330 space to the cell membrane55. However, insulin and exercise have been shown to act 
331 through different pathways, enabling insulin resistant individuals to increase glucose 
332 uptake with exercise. There is evidence that improvements in insulin sensitivity 
333 associated with exercise training are also related to changes in the expression and/or 
334 activity of proteins involved in insulin signal transduction in skeletal muscle such as the 
335 AMP-activated protein kinase (AMPK) and the protein kinase B (Akt) substrate AS16056. 
336 Increased lipid oxidation and/or turnover related to upregulation of the oxidative capacity 
337 of skeletal muscle and the expression of proteins involved in mitochondrial biogenesis is 
338 likely to be a further mechanism improving insulin sensitivity with training57, Significant 
339 gender differences were seen in the study with higher insulin and HOMA-IR in females, 
340 consistent with increased body fat and greater incidence of insulin resistance in females 
341 during childhood and adolescence58 59 60. However, obese adolescent and adult males 
342 have a greater risk of type 2 diabetes mellitus (T2DM) and of the metabolic syndrome 
343 than obese females due to greater visceral fat61 62. Female participants in this study had 
344 greater visceral adiposity than males and also higher body fat than published data for 
345 normal UK females of the same age. The use of oestrogen replacement therapy for 
346 treatment-related ovarian failure after HSCT/TBI in females may be a factor  and 
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347 untreated premature ovarian failure is itself associated with increased metabolic disease63. 
348 Oral hormone replacement therapy (HRT) may promote a greater increase in insulin 
349 resistance than trans-dermal HRT but data supporting this are typically from studies in 
350 older post-menopausal women and may not be applicable to young women with 
351 premature ovarian failure64 65.
352 The general health domain of SF-36 showed significant improvement during the exercise 
353 intervention and during the 6-month follow-up period. The magnitude of this 
354 improvement, however, was less than 1 SD: the size of a change usually accepted as 
355 conferring clinically relevance. Although this improvement is positive and consistent 
356 with what would be expected with exercise training in young people, the SF-36 may not 
357 be a sensitive enough tool in this sample size to detect a clinically relevant change. In 
358 addition the young people in this study reported higher QoL scores than those typically 
359 seen in adults and therefore a positive change may be more difficult to detect Other SF-
360 36 domains showed significant improvements before the exercise intervention started 
361 time1-time2). This suggests that taking part in the study, rather than the specific effects of 
362 the exercise intervention, was of benefit, or that there was familiarisation with the 
363 questionnaire between the time points. MMQL data showed significant improvements in 
364 the school domain during the exercise intervention, and MMQL physical health and 
365 school domains also improved between time 2 and time 4, but it is not clear whether this 
366 can be attributed to the exercise intervention alone. A number of studies employing 
367 exercise interventions have shown improvements in QoL in healthy participants66, cancer 
368 patients on therapy67 68, and cancer survivors69. The stated rationales include 
369 improvements in fitness, self-esteem, body image and resistance to fatigue.
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370 There are some limitations of this study. It was not practical to apply the whole study, 
371 including the intervention, to a control group but the longitudinal design controlled for 
372 the effects of growth and growth hormone over the baseline period. One question is 
373 whether there could be a bias to the more motivated individuals completing the study. 
374 However, we found that reasons for not completing the study were illness and moving 
375 out of the area which were unrelated to motivation. In addition the participants gave very 
376 positive feedback regarding taking part, which is supported by the positive findings in the 
377 QoL scores across the baseline period.
378 Summary: Survivors of HSCT/TBI in childhood were shown to have reduced 
379 cardiorespiratory fitness, associated with increased adiposity and de-conditioning. Female 
380 survivors were more affected than males at baseline, exhibiting increased insulin 
381 resistance and greater visceral fat. A 6-month combined resistance and aerobic exercise 
382 programme resulted in positive changes in cardiorespiratory fitness, measures of insulin 
383 resistance and some measures of QoL without changes in body composition. These data 
384 support the use of physical rehabilitation programmes to reduce metabolic and 
385 cardiovascular risk in HSCT/TBI survivors. 
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621 Legends;
622 Figure 1. Mean (SD) peak a time 1 to time 4 indicating an improvement in 𝑽O𝟐
623 aerobic fitness following the exercise intervention (between time 2 and time 3).
624 Figure 2. Log HOMA-IR at time 1 to time 4 indicating improved insulin resistance 
625 after the exercise intervention (between time 2 and time 3).
626 Figure 3. Quality of life (QoL) scores at time 1 to time 4 indicating improved in QoL 
627 after the exercise intervention (between time 2 and time 3).
628 Table 1. Demographics and treatment details of participantsTable 2. Changes in 𝑽
629 max, Pulse O2, percentage body fat and insulin resistance indicating significant O𝟐
630 improvements in outcomes after the exercise intervention (between time 2 and time 
631 3, pairwise comparisons 2 vs. 3).
632 Normally distributed data is expressed as mean (standard deviation) whereas skewed 
633 data* is expressed as geometric mean (range). Parametric data were compared overall 
634 using one-way analysis of variance (ANOVA) followed by pairwise comparisons using 
635 post-hoc Fisher’s least significance difference (LSD) tests. Skewed data* was log 
636 transformed to attain a normal distribution before parametric testing. Sample size in 
637 pairwise comparisons: 1 vs. 2 (n= 24), 2 vs. 3 (n= 20), 3 vs. 4 (n= 16). Statistically 
638 significant P values are shown in bold.
639
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Table 1. Demographics and treatment details of participants
Demographics and treatments number of participants
Mean (range) age 24 16.7(10.9-24.5)yrs
Mean (range) times since 
HSCT/TBI
24 8.4(2.3-16.0)yrs
Conditioning cyclophosphamide 24 total dose 120mg/kg
Conditioning campath 24 total dose 50mg
Conditioning TBI 24 total dose 14.4Gy; 8 
fractions
CNS boost irradiation 8 6Gy; 4 fractions
Previous cranial irradiation 2 18Gy and 24Gy
GVHD post-transplant 12 oral steroids (n=6) 
topical steroids (n=6)






Pubertal status 2 pre-pubertal,
5 pubertal
13 post-pubertal.
Haemopoietic stem cell transplantation (HSCT/TBI), central nervous system (CNS), graft 
versus host disease (GVHD), growth hormone (GH), growth hormone deficiency (GHD).
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0.002 1 vs. 2: 0.29
2 vs. 3: 0.020











0.20 1 vs. 2: 0.87
2 vs. 3: 0.05











0.036 1 vs. 2: 0.76
2 vs. 3: 0.026
3 vs. 4: 0.61








0.997 1 vs. 2: 0.96
2 vs. 3: 0.86
3 vs. 4: 0.91








0.323 1 vs. 2: 0.26
2 vs. 3: 0.71











0.27 1 vs. 2: 0.76
2 vs. 3: 0.83
3 vs. 4: 0.20
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0.07 1 vs. 2: 0.93
2 vs. 3: 0.03















0.050 1 vs. 2: 0.13
2 vs. 3: 0.03












0.77 1 vs. 2: 0.24
2 vs. 3: 0.02
3 vs. 4: 0.06
Peak rate of oxygen uptake ( peak), rate of oxygen uptake per heart beat (Pulse O2), 𝑉O2
standard deviation (SD), body mass index standard deviation score (BMISDS), homeostatic 
model assessment of insulin resistance (HOMA-IR), repeated measures analysis of variance 
(ANOVA).Normally distributed data is expressed as mean (SD) whereas skewed data* is 
expressed as geometric mean (range). Parametric data were compared overall using repeated 
ANOVA followed by pairwise comparisons using post-hoc Fisher’s least significance 
difference (LSD) tests. Skewed data* was log transformed to attain a normal distribution 
before parametric testing. Sample size in pairwise comparisons: 1 vs. 2 (n= 24), 2 vs. 3 (n= 
20), 3 vs. 4 (n= 16). Statistically significant P values are shown in bold
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QOL Domains at time points 1-4 
SF36 General Health    MMQL Physical Health  MMQL School 
2 vs 3 P<0.01 2 vs 4 P=0.03 2 vs 3 P=0.03 
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